Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2026-01-04 @ 6:49 AM
Study NCT ID:
NCT00602550
Status:
COMPLETED
Last Update Posted:
2018-01-23
First Post:
2007-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalency Study of Zidovudine Under Fasting Conditions
Sponsor:
Roxane Laboratories
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ZIDO-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Elizabeth Ernst, Director, Drug Regulatory Affairs and Medical Affairs
Old Organization:
Roxane Laboratories, Inc.